血液分析器及び試薬のグローバル市場動向（～2019）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 REPORT DESCRIPTION 21
1.3 MARKETS COVERED 22
1.4 STAKEHOLDERS 23
1.5 MARKET SCOPE 24
1.6 RESEARCH METHODOLOGY 24
1.6.1 MARKET SIZE ESTIMATION 26
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 28
1.6.3 MARKET SHARE ESTIMATION 28
1.6.4 KEY DATA FROM SECONDARY SOURCES 29
1.6.5 KEY DATA FROM PRIMARY SOURCES 29
1.6.6 ASSUMPTIONS 31
2 EXECUTIVE SUMMARY 32
3 PREMIUM INSIGHTS 36
3.1 GLOBAL HEMATOLOGY MARKET, BY PRODUCT 36
3.2 HEMATOLOGY MARKET, BY REGION AND PRODUCTS 37
3.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY REGION AND END USER 38
3.4 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION AND REGION 39
3.5 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET,
BY TYPE OF PRODUCT AND REGION 40
4 MARKET OVERVIEW 41
4.1 INTRODUCTION 42
4.2 MARKET SEGMENTATION 43
4.2.1 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE 43
4.2.2 HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY 44
4.2.3 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION 45
4.2.4 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE 45
4.2.5 HEMATOLOGY CONSUMABLES MARKET, BY TYPE 46
4.2.6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER 47
4.2.7 HEMOSTASIS MARKET, BY PRODUCT 47
4.2.8 IMMUNOHEMATOLOGY MARKET, BY PRODUCT 48
4.2.9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY 49
4.3 MARKET DYNAMICS 49
4.3.1 MARKET DRIVERS 50
4.3.1.1 Development of high throughput hematology analyzers 50
4.3.1.2 Increasing usage of basic flow cytometry techniques in modern hematology Analyzers 51
4.3.1.3 Increasing adoption of automated hematology instruments by diagnostic laboratories 52
4.3.1.4 Technological advancements 52
4.3.1.5 Development of high-sensitivity point-of-care (POC) hematology testing 53
4.3.2 RESTRAINTS 54
4.3.2.1 Slow adoption of advanced hematology instruments in emerging economies 54
4.3.2.2 Hematology product recalls 54
4.3.2.3 High cost of hematology analyzers 54
4.3.3 OPPORTUNITIES 55
4.3.3.1 Introduction of digital imaging systems in hematology laboratories 55
4.3.3.2 Growing use of microfluidics technology in hematology analyzers 56
4.3.3.3 Rapid growth of hematology market in emerging countries such as India, China, and Brazil in the future 56

4.3.4 CHALLENGES 57
4.3.4.1 Sustainability of players in the highly competitive market 57
4.3.4.2 Stringent and time-consuming regulatory policies 58
5 INDUSTRY ANALYSIS 59
5.1 INTRODUCTION 59
5.2 SUPPLY CHAIN ANALYSIS 60
5.2.1 KEY INFLUENCERS 61
5.2.2 PORTER’S FIVE FORCES ANALYSIS 63
5.2.2.1 Threat from new entrants 63
5.2.2.2 Threat from substitutes 64
5.2.2.3 Bargaining power of suppliers 65
5.2.2.4 Bargaining power of buyers 65
5.2.2.5 Intensity of competitive rivalry 66
5.3 INDUSTRY TRENDS 67
5.3.1 PARTNERSHIPS AMONG HEMATOLOGY INSTRUMENTS AND CONSUMABLES MANUFACTURERS 67
5.3.2 ACQUISITION OF SMALL PLAYERS 67
5.3.3 INCREASING FOCUS TOWARDS REAGENT RENTAL BUSINESS 68
6 HEMATOLOGY PRODUCTS AND SERVICES MARKET 70
6.1 INTRODUCTION 71
6.2 HEMATOLOGY PRODUCTS MARKET 74
6.2.1 HEMATOLOGY INSTRUMENTS 74
6.2.1.1 Hematology analyzers 76
6.2.1.2 Hematology analyzers market, by type of automation 78
6.2.1.2.1 Fully automated hematology analyzers 79
6.2.1.2.1.1 5-part and 6-part differential hematology analyzers 81
6.2.1.2.1.2 3-part differential hematology analyzers 83
6.2.1.2.2 Semi-automated hematology analyzers 84

6.2.1.3 Hematology analyzers, by complexity 85
6.2.1.3.1 Highly complex clinical laboratory analyzers 86
6.2.1.3.2 Hematology analyzers for point-of-care testing 87
6.2.1.4 Hematology analyzers, by price range 89
6.2.1.4.1 High-end hematology analyzers 90
6.2.1.4.2 Low-range and mid-range hematology analyzers 92
6.2.1.5 Slide stainers/makers 93
6.2.2 HEMATOLOGY CONSUMABLES 95
6.2.2.1 Hematology reagents 96
6.2.2.2 Hematology stains 98
6.2.2.3 Controls and calibrators 99
6.3 SERVICES 101
6.4 HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET 102
6.4.1 INTRODUCTION 102
6.4.2 HEMOSTASIS INSTRUMENTS 105
6.4.3 HEMOSTASIS REAGENTS 106
6.5 IMMUNOHEMATOLOGY INSTRUMENTS AND REAGENTS MARKET 108
6.5.1 INTRODUCTION 108
6.5.2 IMMUNOHEMATOLOGY INSTRUMENTS 110
6.5.3 IMMUNOHEMATOLOGY REAGENTS 112
7 GLOBAL HEMATOLOGY MARKET, BY END USER 114
7.1 INTRODUCTION 115
7.2 CLINICAL TESTING LABORATORIES 118
7.3 STAND-ALONE HOSPITALS 119
7.4 RESEARCH INSTITUTIONS 121
7.4.1 PUBLIC AND PRIVATE RESEARCH CENTERS 122
7.4.2 ACADEMIC INSTITUTIONS 124
7.5 COMMERCIAL ORGANIZATIONS 125

8 GEOGRAPHIC ANALYSIS 128
8.1 INTRODUCTION 129
8.2 NORTH AMERICA 130
8.3 EUROPE 138
8.4 ASIA-PACIFIC 146
8.5 ROW 154
9 COMPETITIVE LANDSCAPE 161
9.1 OVERVIEW 161
9.2 MARKET SHARE ANALYSIS, HEMATOLOGY PRODUCTS AND SERVICES MARKET 161
9.3 MARKET SHARE ANALYSIS, HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET 164
9.4 MARKET SHARE ANALYSIS, IMMUNOHEMATOLOGY PRODUCTS AND SERVICES MARKET 166
9.5 COMPETITIVE SITUATION AND TRENDS 168
9.5.1 NEW PRODUCT LAUNCHES 170
9.5.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 176
9.5.3 MERGERS & ACQUISITIONS 182
9.5.4 EXPANSIONS 185
9.5.5 OTHER DEVELOPMENTS 189
10 COMPANY PROFILES 192
10.1 SYSMEX CORPORATION 192
10.2 BECKMAN COULTER, INC.
(A SUBSIDIARY OF DANAHER CORPORATION) 204
10.3 ABBOTT LABORATORIES 214
10.4 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) 219
10.5 HORIBA, LTD. 228
10.6 BIO-RAD LABORATORIES, INC. 235
10.7 BOULE DIAGNOSTICS AB 246
10.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 251
10.9 NIHON KOHDEN CORPORATION 257
10.10 ROCHE DIAGNOSTICS
(A DIVISION OF F. HOFFMANN-LA ROCHE LTD) 261

*Details on Financials, Product & Services, Key Strategy, & Developments might not be captured in case of unlisted companies
* SWOT Analysis and MNM View are provided for top-5 companies only